Gyre Therapeutics (GYRE) Cash & Equivalents Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 917.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 917.36% |
| Dec 31, 2025 | 110.81% |
| Sep 30, 2025 | 154.65% |
| Jun 30, 2025 | 77.92% |
| Mar 31, 2025 | -57.55% |
| Dec 31, 2024 | -64.79% |
| Sep 30, 2024 | 621.18% |
| Jun 30, 2024 | 39.65% |
| Mar 31, 2024 | -31.35% |
| Dec 31, 2023 | 33.10% |
| Sep 30, 2023 | -90.48% |
| Jun 30, 2023 | -84.71% |
| Mar 31, 2023 | -63.67% |
| Dec 31, 2022 | -43.23% |
| Sep 30, 2022 | -60.95% |
| Jun 30, 2022 | 2.41% |
| Mar 31, 2022 | -67.46% |
| Dec 31, 2021 | -45.85% |
| Sep 30, 2021 | 137.36% |
| Jun 30, 2021 | 24.21% |
| Mar 31, 2021 | 52.07% |
| Dec 31, 2020 | 6.55% |
| Sep 30, 2020 | -70.68% |
| Jun 30, 2020 | 241.67% |
| Mar 31, 2020 | 181.19% |
| Dec 31, 2019 | -35.44% |
| Sep 30, 2019 | 136.12% |
| Jun 30, 2019 | -62.72% |
| Mar 31, 2019 | -80.23% |
| Dec 31, 2018 | 216.31% |
| Sep 30, 2018 | 228.06% |
| Jun 30, 2018 | 43.67% |
| Mar 31, 2018 | 770.78% |
| Dec 31, 2017 | 266.70% |
| Sep 30, 2017 | 17.77% |
| Jun 30, 2017 | 185.78% |
| Mar 31, 2017 | -29.38% |
| Dec 31, 2016 | -64.72% |
| Sep 30, 2016 | -59.66% |
| Jun 30, 2016 | 391.46% |
| Mar 31, 2016 | 894.68% |
| Dec 31, 2015 | 1,784.46% |
| Sep 30, 2015 | 541.02% |
| Jun 30, 2015 | -94.69% |
| Mar 31, 2015 | -95.41% |
| Dec 31, 2014 | -45.40% |
| Sep 30, 2014 | -94.16% |
| Jun 30, 2014 | -31.15% |
| Mar 31, 2014 | -35.53% |
| Dec 31, 2013 | -16.85% |
| Sep 30, 2013 | -21.05% |
| Jun 30, 2013 | -11.98% |
| Mar 31, 2013 | -21.21% |
| Dec 31, 2012 | -96.83% |
| Sep 30, 2012 | -40.09% |
| Jun 30, 2012 | -57.39% |
| Mar 31, 2012 | -36.14% |
| Dec 31, 2011 | -35.31% |
| Sep 30, 2011 | -29.74% |
| Jun 30, 2011 | -24.13% |